Systemic antifungal strategies in allogeneic hematopoietic stem cell recipients hospitalized in french hematology units: a post-hoc analysis of the cross-sectional observational AFHEM study.

Date publication

avril 2022

Journal

BMC infectious diseases

Auteurs

Membres identifiés du Cancéropôle Est :
Dr CAILLOT Denis , Pr HERBRECHT Raoul

Tous les auteurs :
Michallet M, Cheikh JE, Herbrecht R, Yakoub-Agha I, Caillot D, Gangneux JP

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/35397492

Résumé

Invasive fungal diseases (IFD) remain a major complication of allogeneic hematopoietic stem cell transplantation (alloHSCT) and are associated with high mortality rates in patients receiving alloHSCT. Antifungal prophylaxis is increasingly being used in the management of IFDs in patients receiving alloHSCT.

Mots clés

Allogeneic hematopoietic stem cell transplantation, Antifungal stewardship, Invasive fungal diseases, Prophylaxis, Prospective, observational study

Référence

BMC Infect Dis. 2022 Apr 9;22(1):352